23 May 2013
Keywords: novartis, tekturna, hct, cleared, fda, swiss, drug
Article | 28 January 2008
Swiss drug major Novartis says that its blood pressure treatment Tekturna HCT (aliskiren and hydrochlorothiazide) has been approved by
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 January 2008
© 2013 thepharmaletter.com